This report describes a patient found post-mortem to have high-grade metastatic PCa with tumor p53 overexpression by immunohistochemistry (IHC) and a TP53 codon 72 variant identified by next-generation sequencing (NGS). This evidence concerns the gene TP53 and posterior cortical atrophy.